The cost of developing new drugs is a major issue for drug development companies, the industry, and consumers as well. R&D and human clinical tests, integral components of the drug-development process, are themselves elaborate and costly.
More: continued here
If you like this post, please buy me a beer for $3 8-)
Blogsphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg
RSS feed for comments on this post | TrackBack URI for this post


















